HealthResJ, health, medicine, nursing, research https://ejournals.epublishing.ekt.gr/index.php/HealthResJ/sitemap

The COVID-19 pandemic and the incidence of acute coronary syndromes at General Hospital of Veroia


Published: Jan 9, 2024
Keywords:
acute coronary syndromes, cardiac catheterizations, COVID-19 pandemic, hospitalizations.
Evangelos Sdogkos
https://orcid.org/0000-0001-7821-797X
Pavlos Roditis
https://orcid.org/0000-0001-8884-1370
Antonios Papadopoulos
https://orcid.org/0000-0002-8034-879X
Anila Spahiu
Andreas Aidinis
Maria Pliatsika
https://orcid.org/0000-0001-9063-7432
Ioannis Vogiatzis
Abstract

Background: Although deaths from Acute Coronary Syndromes (ACS) are the most prevalent globally, during the outbreak of the new SARS-CoV-2 coronavirus pandemic, there was a declining trend in hospital admissions for ACS patients. Inevitably a reduction of invasive procedures in cardiac catheterization laboratories was observed. Moreover, an increase in sudden out-of-hospital cardiac deaths was recorded. On the other hand, patients that eventually treated in the hospital had a much worse outcome in terms of cardiac function. Inadequate treatment of acute myocardial infarction resulted in a further increase in mortality due to coronary artery disease.


The aim of our study was the comparison of admissions of the patients with ACS before and during the COVID-19 pandemic.


Methods: A retrospective single center study was conducted. We recorded all admissions with ACS underwent  invasive interventions during the period of lockdown due to COVID-19 pandemic, in Greece, from 16 March 2020 to 1 May 2020 (study period A), as well as in the period of gradual withdraw of restrictions from 2 May 2020 to 1 June 2020 (study period B),. The data were compared with those of the periods of 2019 (control period A and B).


Results: One hundred thirty eight patients were the group of study period and 158 were the group of the control period. The reduction rate was 12.7% in study period. The largest decrease in admissions concerned with elderly patients over 75 years old, as well as females (by 52% - 53% respectively). The severity of the restrictions but also the fear of the spread of the coronavirus may be relevant to the insufficient seek of help for these groups of patients.


Conclusion: Our study showed that during the pandemic period, the invasive interventions were fewer than those of 2019. However, the expected reduction of catheterizations during this two and a half months period was mitigated by the increase of inter-hospital transfers of patients with ACS from neighboring hospitals, without a catheterization laboratory.

Article Details
  • Section
  • Original Articles
Downloads
Download data is not yet available.
References
Guerchicoff A, Brener S, Maehara A, et al. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction). JACC Cardiovasc Interv 2014; 7(7): 733-740.
Nallamothu BK, Normand S-LT, Wang Y, et al. Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospec-tive study. Lancet. 2015; 385: 1114–1122.
Solomon M, McNulty E, Rana J, Leong T, Lee C, Ambrosy A, et al. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. NEJM 2020, DOI: 10.1056/NEJMc2015630
Garcia S, Albaghdadi M, Meraj P, Schmidt C, Garberich R, Jaffer F, et al. Reduction in STsegment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 2020 April 9 (Epub ahead of print).
De Filippo O, D’Ascenzo F, Angelini F, Bocchino P, Conrot-to F, Saglietto A. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N Engl J Med, 2020;383(1): 88-89
Wu J, Mamas M, Rashid M, Weston C, Hains J, Luescher T, et al. Patient response, treatments and mortality for acute myocardial infarction during the COVID-19 pandemic. Eu-ropean Heart Journal-Quality of Care and Clinical Out-comes. 2020; doi.org/10.1093/ehjqcco/qcaa062
Liew M, Siow W, Yau Y, See K. Safe patient transport for COVID-19. Critical Care 2020; 24: 94
Nishiga M, Wang D. Han Y, Lewis D, Wu J. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020, doi.org/10.1038/s41569-020-0413-9
De Rosa S, Spaccarotella C, Basso C, Calabrò M, Curcio A, Filardi P, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J, 2020;41(22): 2083-2088
Baldi E, Sechi G, Mare C, Canevari F, Brancaglione A, Primi R, et al. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy. N Engl J Med, 2020;383(5): 496-498
Leor O, Álvarez B, Ojeda S, Moreiras J, Rumoroso R, Palop R, et al. Impact of the COVID-19 pandemic on interven-tional cardiology activity in Spain. Rec Interv Cardiol. 2020;2(2): 82-89
Amorim G, Camm C, Gajendragadkar P, De Maria G, Arsac C, Laroche C, et al. Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology. European Heart Journal - Quality of Care and Clinical Outcomes,2020;6: 210–216
Papafaklis M, Katsouras C, Tsigkas G, Toutouzas K, Davlou-ros P, Hahalis G, et al. “Missing” acute coronary syndrome hospitalizations during the COVID ‐19 era in Greece: Medi-cal care avoidance combined with a true reduction in inci-dence? Clin Cardiol. 2020: 1–8
Rowland B, Kunadian V. Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic. Heart 2020;0:1–6
Ashraf S, Ilyas S, Alraies C. Acute coronary syndrome in the time of the COVID-19 pandemic. European Heart Journal 2020;41: 2089–2091
Sharma G, Volgman A, Michos E. Sex Differences in Mortal-ity From COVID-19 Pandemic. JACC Case Rep. 2020;2(9): 1407–1410
Van Zyl-Smit R, Richards G, Leone F. Tobacco smoking and COVID-19 infection. The Lancet. 2020; 8(7): 664-665